IV ketamine for chronic daily headaches
Treatments studied
Part of Brain & nervous system, Pain clinical trials.
This trial tests whether an IV dose of ketamine can reduce chronic daily headaches and is safe for people with this condition. It may help by lowering headache frequency and severity, but it also has several medicine and health-related safety checks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re between 18 and 75 years old
- You have chronic daily headaches for at least 3 months (headaches on 15+ days per month, lasting 4+ hours)
- Your recent blood tests show your liver and kidneys are working normally
- You are not pregnant or breastfeeding
- You are not taking certain headache-related medicines recently (CGRP blockers in 1 month or Botox in 3 months)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether ketamine, given with talk therapy, can help people whose depression hasn't improved with at least two antidepressants. It aims to see if this combination can reduce depression symptoms.
This trial tests if ketamine combined with talk therapy helps people with both chronic pain and PTSD. Participants receive ketamine through an IV in group therapy sessions over several weeks, with the goal of reducing pain and PTSD symptoms.
This study tests whether giving two pain-relieving medicines, ketamine and lidocaine, through an IV can help adults with chronic migraine that hasn't improved with other treatments. The goal is to see if this treatment reduces migraine pain and improves daily life.
This trial tests if ketamine can help people with long-term health issues. It aims to find new treatments for chronic conditions that haven't responded well to other therapies.
This study tests if intravenous ketamine can help people with treatment-resistant depression who haven't found relief from at least two other treatments. If you qualify, you'll receive ketamine infusions to see if it improves your mood.
This trial tests whether a single dose of ketamine can quickly improve depression by studying brain chemical changes using MRI. It's for people with treatment-resistant depression who haven't used ketamine before.
Hear when a new Chronic Daily Headache trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.